CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
53 hedge funds and large institutions have $84M invested in Carisma Therapeutics in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% more funds holding
Funds holding: 37 → 53 (+16)
9.96% more ownership
Funds ownership: 13.84% → 23.8% (+10%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
53
Holding in Top 10
1
Calls
$5.49M
Puts
$1.63M
Top Buyers
| 1 | +$14.5M | |
| 2 | +$8.28M | |
| 3 | +$3.87M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.69M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.77M |
Top Sellers
| 1 | -$1.28M | |
| 2 | -$159K | |
| 3 | -$145K | |
| 4 |
Millennium Management
New York
|
-$111K |
| 5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$61.7K |